Metraipolis › archive › dc_f663b81079e5

COVID-19 mortality rate and its associated factors during the first and second waves in Nigeria — Europe PMC PMID:36962290

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36962290
DOI
10.1371/journal.pgph.0000169
License (as archived)
CC0-1.0
Archived
2026-10-18T08:17:41.959Z
SHA-256 of the archived text
a4a7e9106a5abba0c10a10dab25ec594432c930dd1e5da07aba1f107c7d1b2e1
Stable URL of this page
https://metraipolis.com/documento/dc_f663b81079e5

How to cite

COVID-19 mortality rate and its associated factors during the first and second waves in Nigeria — Europe PMC PMID:36962290 — Europe PMC (en), https://europepmc.org/article/MED/36962290 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f663b81079e5 (Metraipolis archive dc_f663b81079e5, sha256 a4a7e9106a5abba0c10a10dab25ec594432c930dd1e5da07aba1f107c7d1b2e1)
BibTeX
@misc{dcf663b81079e5,
  title = {COVID-19 mortality rate and its associated factors during the first and second waves in Nigeria — Europe PMC PMID:36962290},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36962290},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f663b81079e5; sha256 a4a7e9106a5abba0c10a10dab25ec594432c930dd1e5da07aba1f107c7d1b2e1},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36962290. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

COVID-19 mortality rate has not been formally assessed in Nigeria. Thus, we aimed to address this gap and identify associated mortality risk factors during the first and second waves in Nigeria. This was a retrospective analysis of national surveillance data from all 37 States in Nigeria between February 27, 2020, and April 3, 2021. The outcome variable was mortality amongst persons who tested positive for SARS-CoV-2 by Reverse-Transcriptase Polymerase Chain Reaction. Incidence rates of COVID-19 mortality was calculated by dividing the number of deaths by total person-time (in days) contributed by the entire study population and presented per 100,000 person-days with 95% Confidence Intervals (95% CI). Adjusted negative binomial regression was used to identify factors associated with COVID-19 mortality. Findings are presented as adjusted Incidence Rate Ratios (aIRR) with 95% CI. The first wave included 65,790 COVID-19 patients, of whom 994 (1∙51%) died; the second wave included 91,089 patients, of whom 513 (0∙56%) died. The incidence rate of COVID-19 mortality was higher in the first wave [54∙25 (95% CI: 50∙98-57∙73)] than in the second wave [19∙19 (17∙60-20∙93)]. Factors independently associated with increased risk of COVID-19 mortality in both waves were: age ≥45 years, male gender [first wave aIRR 1∙65 (1∙35-2∙02) and second wave 1∙52 (1∙11-2∙06)], being symptomatic [aIRR 3∙17 (2∙59-3∙89) and 3∙04 (2∙20-4∙21)], and being hospitalised [aIRR 4∙19 (3∙26-5∙39) and 7∙84 (4∙90-12∙54)]. Relative to South-West, residency in the South-South and North-West was associated with an increased risk of COVID-19 mortality in both waves. In conclusion, the rate of COVID-19 mortality in Nigeria was higher in the first wave than in the second wave, suggesting an improvement in public health response and clinical care in the second wave. However, this needs to be interpreted with caution given the inherent limitations of the country's surveillance system during the study.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLOS global public health, 2022 (prima pubblicazione 2022-06-09).
Identificativi: PMID 36962290 · PMCID PMC10022313 · DOI 10.1371/journal.pgph.0000169.
Pagina: https://europepmc.org/article/MED/36962290 — https://doi.org/10.1371/journal.pgph.0000169. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-18T08:17:26.707Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.